Corundum Group, Inc. Merck & Co., Inc. Transaction History
Corundum Group, Inc.
- $254 Million
- Q2 2024
A detailed history of Corundum Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Corundum Group, Inc. holds 16,979 shares of MRK stock, worth $1.86 Million. This represents 0.83% of its overall portfolio holdings.
Number of Shares
16,979
Previous 10,486
61.92%
Holding current value
$1.86 Million
Previous $1.38 Million
51.99%
% of portfolio
0.83%
Previous 0.67%
Shares
25 transactions
Others Institutions Holding MRK
# of Institutions
3,826Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$26.9 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$22.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$12.9 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.96 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.26 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $278B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...